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BACKGROUND The coronary sinus (CS) Reducer is a recently intro-
duced device to treat patients with severe anginal symptoms who are
refractory to optimal medical therapy and not amenable for conven-
tional revascularization. We aimed to assess the safety and efﬁcacy of
the CS Reducer in a “real world” cohort of patients with refractory
angina.
METHODS This is a single center retrospective registry. Patients with
severe anginal symptoms, objective evidence of myocardial ischemia
using any modality and without options for conventional revascu-
larization were regarded eligible for CS Reducer implantation.
RESULTS Twenty-three patients (74.0% male, mean age 708
years) underwent CS Reducer implantation (91.0% previous bypass
surgery, 48.0% previous myocardial infarction, 83.0% previous
percutaneous intervention, 52.0% diabetes mellitus). The safety
endpoint (successful delivery and deployment) was met in all pa-
tients. One patient suffered a procedure-related access site
complication (neck hematoma), which was treated conservatively.
After a median follow-up of 9 [8-14] months the efﬁcacy endpoint
(any reduction in Canadian Cardiovascular Society (CCS) class with
revascularization free survival) was reached in 17 patients (74.0%).
The majority of patients (78.3%) experienced an improvement of
clinical symptoms: 8 (34.8%) by 1 CCS class, 8 (34.8%) by 2 CCS
classes (1 of them underwent a revascularization at follow up) and 2
(8.7%) by 3 CCS classes. One patient died 4 month after implanta-
tion because of progressive heart failure (no association with the CS
Reducer implantation).
CONCLUSIONS In this single center ’real-world’ experience, the CS
Reducer implantation was safe and demonstrated clinical efﬁcacy in
the treatment of refractory angina at mid-term follow-up.CATEGORIES STRUCTURAL: Heart Failure
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BACKGROUND Although fractional ﬂow reserve (FFR) is the gold
standard in functional assessment of intermediate coronary stenosis,
it lacks anatomical information essential for risk stratiﬁcation of pla-
que and guidance of PCI. In IVUS, integrated backscatter (IB) values of
blood speckles, calculated as the average power of backscattered
radiofrequency (RF) signals from blood, have been shown to change as
a function of blood ﬂow velocity. This study aimed to investigate
potential utility of RF-IVUS for assessment of functional signiﬁcance
of intermediate coronary stenosis.
METHODS In 42 patients with intermediate lesions in 1 epicardial
coronary arteries, 45 arteries (28 left anterior descending; 3 left
circumﬂex; 14 right coronary artery) were evaluated by IB-IVUS and
intracoronary pressure measurements. Average IB values of blood
speckles within the lumen were measured at proximal (a segment
near the oriﬁce of the artery) and distal (a disease-free segment
>10 mm distal to the tightest site) segments to the lesion. As IB is a
logarithmic variable, a ratio of the distal and proximal IB values was
calculated as DIB between the 2 sites. As control, FFR during hyper-
emia and instantaneous wave-free ratio (iFR) were obtained using a
coronary pressure wire.
RESULTS Overall, the minimum lumen area (MLA) of the lesions
ranged from 1.0 to 7.4 mm2 (median 2.1 mm2). DIB signiﬁcantly
correlated with both FFR and iFR (Figure), which was also conﬁrmed
in a subset of lesions with small MLA (deﬁned as < the median value).
Receiver operating characteristic (ROC) curve analyses identiﬁed the
best cut-off value as 7.25 of DIB for predicting FFR 0.8 (sensitivity
100%; speciﬁcity 88%; positive predictive value 86%; negative
predictive value 100%, accuracy 93%), and 9.14 of DIB for predicting
iFR 0.89 (sensitivity 100%; speciﬁcity 79%; positive predictive
value 61%; negative predictive value 100%; accuracy 84%).
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timate coronary physiology across intermediate stenosis, demon-
strating signiﬁcant association of blood DIB with FFR and iFR even in
relatively small MLA lesions. Further investigation is warranted to
conﬁrm the potential utility of RF-IVUS for hybrid (both anatomic and
functional) assessment of coronary artery disease, which may be
helpful for time and cost-effective resource utilization.
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BACKGROUND To determine the speciﬁc cause of death and their
potential inﬂuencing factors in patients with complex coronary artery
disease who underwent percutaneous coronary intervention (PCI) or
coronary artery bypass grafting (CABG) in the SYNTAX randomized
trial and nested registries.
METHODS An independent Clinical Events Committee consisting of
expert physicians blinded to the study treatment, sub-classiﬁed cau-
ses of death in cardiovascular (cardiac and vascular), non-cardiovas-
cular and undetermined according to the trial protocol. Cardiac deaths
were classiﬁed as sudden cardiac, myocardial infarction (MI)-related
and other cardiac deaths. Multivariate models were constructed to
identify independent predictors of all-cause and cardiac death after
PCI and CABG.
RESULTS In the randomized cohort, during 5-year follow-up, there
were 123 deaths after PCI and 97 deaths after CABG. After PCI, the
majority of deaths were cardiovascular (67.5%) and as a result of MI
(29.3%), whereas after CABG 49.4% of deaths were cardiovascular
with the largest cause being heart failure, arrhythmia or other
causes (24.6%). The cumulative incidence rates of all-cause death
were not signiﬁcantly different between CABG and PCI (11.4 vs.
13.9%, respectively; P¼0.10), while there were signiﬁcant differ-
ences in terms of cardiovascular (5.8 vs. 9.6%, respectively;
P¼0.008) and cardiac (5.3 vs. 9.0%, respectively; P¼0.003) death,
caused primarily by a reduction in MI-related death with CABG as
compared with PCI (0.4 vs. 4.1%, respectively; P<0.0001). The
difference in MI-related death was seen largely in patients with
diabetes, three-vessel disease, or high SYNTAX scores. Independent
predictors of all-cause and cardiac death consisted of baseline,
procedural and post-procedural variables, with important predictorsbeing discharge medication use and adverse events during follow-
up. Results for the nested registries were similar, although the
death rate in the PCI registry was higher and more often the result
of non-cardiovascular causes.
CONCLUSIONS The rate of all-cause death at 5 years was not signiﬁ-
cantly different between PCI and CABG. However, CABG in compari-
son with PCI was associated with a signiﬁcantly reduced rate of MI-
related death, which was the leading cause of death after PCI,
particularly in patients with complex disease and in the presence of
diabetes.
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BACKGROUND In the past two decades, signiﬁcant advances have
occurred in the management of coronary artery disease. It is un-
clear whether increased options for treatment, improved technology
and expanded available evidence have translated into nationwide
changes in comorbidity proﬁles and outcomes of patients present-
ing for PCI.
METHODS 3,387,976 Medicare beneﬁciaries >¼ 65 yrs of age who
underwent PCI from 1/2000 -11/2012 were included. Comorbidities
were determined using ICD-9-CM diagnostic codes from any hospi-
talization within 1 yr prior to index admission. Trends in patient
characteristics and hospital outcomes were assessed with Cochran-
Armitage trend tests. Long-term survival was examined with Kaplan-
Meier survival curves.
RESULTS From 2000 through 2006, the number of patients un-
dergoing PCI increased from 246,528 to 318, 622, and then
decreased to 161,667 in 2012 (11 months of data). There was a sig-
niﬁcant increase over time in the incidence of all comorbidities
examined, including HTN, diabetes, PVD, history of stroke or TIA,
heart failure, COPD, renal failure and atrial ﬁbrillation. The number
of patients presenting with acute MI increased from 26.9% in 2000
to 45.8% in 2012. Overall, 43.1% of the PCI admissions were elec-
tive, 38.3% were urgent and 18.6% were emergent. Angioplasty was
performed in 9.6%, and PCI with stent placement in 90.4%. The
use of bare metal stents declined from 85.7% in 2000 to 23.5% in
2012, with a corresponding increase in the use of drug-eluting
stents (DES) (70.3% in 2012). The use of DES peaked in 2005 at
84.1%. Hospital mortality increased from 2.1% in 2000 to 3.1% in
2012, despite reaching a nadir of 1.8% from 2004-2006. Hospital
mortality was 1% for elective, 2.1% for urgent and 4.5% for emer-
gent admissions. The biggest increase in mortality over time was
seen for elective admissions from 0.8% in 2000 to 3.4% in 2012.
Compared to year 2000, adjusted hospital mortality odds ratio was
1.42 in 2012 (95% CI 1.36 – 1.48), signifying 42% increase likelihood
of death with PCI during the study period after accounting for
differences in baseline characteristics. Overall survival was 93% at 6
months, 90% at 1 year, 80% at 3 years and 69% at 5 years. From
2000 through 2006, 5- year survival remained at 70%, and subse-
quently modestly declined to 66% for 2009.
